Adaptive Biotechnologies Corp Stock Price on November 21, 2024
| ADPT Stock | USD 6.44 0.05 0.78% |
Below is the normalized historical share price chart for Adaptive Biotechnologies Corp extending back to June 27, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adaptive Biotechnologies stands at 6.44, as last reported on the 27th of December, with the highest price reaching 6.51 and the lowest price hitting 6.30 during the day.
If you're considering investing in Adaptive Stock, it is important to understand the factors that can impact its price. Adaptive Biotechnologies appears to be slightly risky, given 3 months investment horizon. Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.0961, which signifies that the company had a 0.0961% return per unit of standard deviation over the last 3 months. By analyzing Adaptive Biotechnologies' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please makes use of Adaptive Biotechnologies' mean deviation of 4.15, and Risk Adjusted Performance of 0.1212 to double-check if our risk estimates are consistent with your expectations.
At this time, Adaptive Biotechnologies' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 811.6 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 10.3 K in 2024. . At this time, Adaptive Biotechnologies' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.41 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.06) in 2024. Adaptive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of June 2019 | 200 Day MA 4.2442 | 50 Day MA 5.5366 | Beta 1.447 |
Adaptive |
Sharpe Ratio = 0.0961
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ADPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.2 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.5 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Adaptive Biotechnologies is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adaptive Biotechnologies by adding it to a well-diversified portfolio.
Price Book 4.2142 | Enterprise Value Ebitda (1.00) | Price Sales 5.3194 | Shares Float 76.8 M | Wall Street Target Price 7.5833 |
Related Headline
Royalty Pharma Headline on 21st of November 2024
Overbrook Management Corp Sells 59,504 Shares of Royalty Pha... by news.google.com
Overbrook Management Corp Sells 59,504 Shares of Royalty Pharma plc MarketBeat
Adaptive Biotechnologies Valuation on November 21, 2024
It is possible to determine the worth of Adaptive Biotechnologies on a given historical date. On November 21, 2024 Adaptive was worth 4.39 at the beginning of the trading date compared to the closed value of 4.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adaptive Biotechnologies stock. Still, in general, we apply an absolute valuation method to find Adaptive Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adaptive Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adaptive Biotechnologies' related companies.
| Open | High | Low | Close | Volume | |
| 4.42 | 4.57 | 4.33 | 4.42 | 1,819,355 | |
11/21/2024 | 4.39 | 4.49 | 4.27 | 4.37 | 1,586,015 |
| 4.35 | 4.70 | 4.29 | 4.69 | 2,328,368 |
| Backtest Adaptive Biotechnologies | | | Adaptive Biotechnologies History | | | Adaptive Biotechnologies Valuation | Previous | Next |
Adaptive Biotechnologies Trading Date Momentum on November 21, 2024
| On November 22 2024 Adaptive Biotechnologies Corp was traded for 4.69 at the closing time. The top price for the day was 4.70 and the lowest listed price was 4.29 . The trading volume for the day was 2.3 M. The trading history from November 22, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 7.32% . The overall trading delta against the current closing price is 36.16% . |
Adaptive Biotechnologies Fundamentals Correlations and Trends
By evaluating Adaptive Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adaptive Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adaptive financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Adaptive Biotechnologies Stock history
Adaptive Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adaptive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adaptive Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adaptive Biotechnologies stock prices may prove useful in developing a viable investing in Adaptive Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 144.4 M | 131.8 M | |
| Net Loss | -180.2 M | -189.2 M |
Adaptive Biotechnologies Quarterly Net Working Capital |
|
Adaptive Biotechnologies Stock Technical Analysis
Adaptive Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Adaptive Biotechnologies Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Adaptive Biotechnologies Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Adaptive Biotechnologies December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Adaptive Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adaptive Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adaptive Biotechnologies stock market strength indicators, traders can identify Adaptive Biotechnologies Corp entry and exit signals to maximize returns
Adaptive Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adaptive Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adaptive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adaptive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1212 | |||
| Jensen Alpha | 0.8141 | |||
| Total Risk Alpha | 0.4921 | |||
| Sortino Ratio | 0.1795 | |||
| Treynor Ratio | (4.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.